Cargando…
Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report
BACKGROUND: Intraocular medulloepithelioma is commonly treated with primary enucleation. Conservative treatment options include brachytherapy, local resection and/or cryotherapy in selected cases. We report for the first time the use of targeted chemotherapy to treat a ciliary body medulloepitheliom...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302148/ https://www.ncbi.nlm.nih.gov/pubmed/32552699 http://dx.doi.org/10.1186/s12886-020-01512-y |
_version_ | 1783547794399690752 |
---|---|
author | Stathopoulos, Christina Gaillard, Marie-Claire Schneider, Julie Munier, Francis L. |
author_facet | Stathopoulos, Christina Gaillard, Marie-Claire Schneider, Julie Munier, Francis L. |
author_sort | Stathopoulos, Christina |
collection | PubMed |
description | BACKGROUND: Intraocular medulloepithelioma is commonly treated with primary enucleation. Conservative treatment options include brachytherapy, local resection and/or cryotherapy in selected cases. We report for the first time the use of targeted chemotherapy to treat a ciliary body medulloepithelioma with aqueous and vitreous seeding. CASE PRESENTATION: A 17-month-old boy with a diagnosis of ciliary body medulloepithelioma with concomitant seeding and neovascular glaucoma in the right eye was seen for a second opinion after parental refusal of enucleation. Examination under anesthesia showed multiple free-floating cysts in the pupillary area associated with iris neovascularization and a subluxated and notched lens. Ultrasound biomicroscopy revealed a partially cystic mass adjacent to the ciliary body between the 5 and 9 o’clock meridians as well as multiple nodules in the posterior chamber invading the anterior vitreous inferiorly. Fluorescein angiography demonstrated peripheral retinal ischemia. Left eye was unremarkable. Diagnosis of intraocular medulloepithelioma with no extraocular invasion was confirmed and conservative treatment initiated with combined intracameral and intravitreal melphalan injections given according to the previously described safety-enhanced technique. Ciliary tumor and seeding totally regressed after a total of 3 combined intracameral (total dose 8.1 μg) and intravitreal (total dose 70 μg) melphalan injections given every 7–10 days. Ischemic retina was treated with cryoablation as necessary. Three years later, ab interno trabeculotomy followed by 360° gonioscopy-assisted transluminal trabeculotomy 6 months later was performed for uncontrolled intraocular pressure despite antihypertensive drugs combined to cyclophotocoagulation and 7 intravitreal anti-VEGF injections for recurrent iris neovascularization. Cataract was removed at the same operative time. The child has remained disease- and metastasis-free at a 5-year follow-up since the last melphalan injection (25-month follow-up after the combined lensectomy-trabeculotomy) with a controlled intraocular pressure under topical quadritherapy and a best corrected Snellen visual acuity of 0.08. CONCLUSIONS: We report for the first time complete regression of a non-infiltrating ciliary body medulloepithelioma with seeding achieved with only a small number of intracameral and intravitreal melphalan injections. Concomitant secondary neovascular glaucoma and cataract needed appropriate management to allow long-term eye and vision preservation. |
format | Online Article Text |
id | pubmed-7302148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73021482020-06-19 Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report Stathopoulos, Christina Gaillard, Marie-Claire Schneider, Julie Munier, Francis L. BMC Ophthalmol Case Report BACKGROUND: Intraocular medulloepithelioma is commonly treated with primary enucleation. Conservative treatment options include brachytherapy, local resection and/or cryotherapy in selected cases. We report for the first time the use of targeted chemotherapy to treat a ciliary body medulloepithelioma with aqueous and vitreous seeding. CASE PRESENTATION: A 17-month-old boy with a diagnosis of ciliary body medulloepithelioma with concomitant seeding and neovascular glaucoma in the right eye was seen for a second opinion after parental refusal of enucleation. Examination under anesthesia showed multiple free-floating cysts in the pupillary area associated with iris neovascularization and a subluxated and notched lens. Ultrasound biomicroscopy revealed a partially cystic mass adjacent to the ciliary body between the 5 and 9 o’clock meridians as well as multiple nodules in the posterior chamber invading the anterior vitreous inferiorly. Fluorescein angiography demonstrated peripheral retinal ischemia. Left eye was unremarkable. Diagnosis of intraocular medulloepithelioma with no extraocular invasion was confirmed and conservative treatment initiated with combined intracameral and intravitreal melphalan injections given according to the previously described safety-enhanced technique. Ciliary tumor and seeding totally regressed after a total of 3 combined intracameral (total dose 8.1 μg) and intravitreal (total dose 70 μg) melphalan injections given every 7–10 days. Ischemic retina was treated with cryoablation as necessary. Three years later, ab interno trabeculotomy followed by 360° gonioscopy-assisted transluminal trabeculotomy 6 months later was performed for uncontrolled intraocular pressure despite antihypertensive drugs combined to cyclophotocoagulation and 7 intravitreal anti-VEGF injections for recurrent iris neovascularization. Cataract was removed at the same operative time. The child has remained disease- and metastasis-free at a 5-year follow-up since the last melphalan injection (25-month follow-up after the combined lensectomy-trabeculotomy) with a controlled intraocular pressure under topical quadritherapy and a best corrected Snellen visual acuity of 0.08. CONCLUSIONS: We report for the first time complete regression of a non-infiltrating ciliary body medulloepithelioma with seeding achieved with only a small number of intracameral and intravitreal melphalan injections. Concomitant secondary neovascular glaucoma and cataract needed appropriate management to allow long-term eye and vision preservation. BioMed Central 2020-06-18 /pmc/articles/PMC7302148/ /pubmed/32552699 http://dx.doi.org/10.1186/s12886-020-01512-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Stathopoulos, Christina Gaillard, Marie-Claire Schneider, Julie Munier, Francis L. Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report |
title | Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report |
title_full | Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report |
title_fullStr | Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report |
title_full_unstemmed | Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report |
title_short | Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report |
title_sort | successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302148/ https://www.ncbi.nlm.nih.gov/pubmed/32552699 http://dx.doi.org/10.1186/s12886-020-01512-y |
work_keys_str_mv | AT stathopouloschristina successfultreatmentofciliarybodymedulloepitheliomawithintraocularmelphalanchemotherapyacasereport AT gaillardmarieclaire successfultreatmentofciliarybodymedulloepitheliomawithintraocularmelphalanchemotherapyacasereport AT schneiderjulie successfultreatmentofciliarybodymedulloepitheliomawithintraocularmelphalanchemotherapyacasereport AT munierfrancisl successfultreatmentofciliarybodymedulloepitheliomawithintraocularmelphalanchemotherapyacasereport |